Match Document Document Title
6326360 Bubbling enteric coated preparations  
An object of the present invention is to obtain an oral glycyrrhizin preparation not only manufacturable by a simple method but also having an excellent property of being absorbed from the...
6319895 Lactoferrin tablets  
Lactoferrin tablets comprising as the active ingredients lactoferrin and lactulose and having a horizontal hardness of at least 4 kg and a vertical hardness of at least 3 kg; and lactoferrin...
6316417 Parenteral formulations comprising carbamazepine or its derivatives  
The invention is concerned with a parenteral formulation comprising a 5H-dibenz(b,f)azepine-5-carboxamide and an aqueous-based solvent. The parenteral formulation is useful in the treatment of...
6313099 Use of stereoisomers of calendula gylcosides for the treatment of psoriasis  
Use of stereoisomeric glycosidic compounds of formula (I) as pharmaceutical agents against psoriasis, compounds therefor and pharmaceutical formulations thereof wherein R 1 and R 2 are...
6310042 Derivatives of carbohydrates and compositions containing them  
The present invention relates to derivatives of phosphorylated carbohydrates and pharmaceutical compositions comprising as a pharmaceutically active ingredient at least one of these compounds.
6310043 Treatment of bacterial infections  
Compounds which bind to toxins associated with enteric bacterial infection, compositions including the compounds, methods for the neutralization of toxins in a patient, and methods for the...
6306828 Enantiomerically-enhanced nutritional energy substrates  
Synthetic enantiomeric esters are employed as energy substrates for parenteral or enteral nutritional formulations. The substrates are provided in substantially monoisomeric or anomeric forms...
6306915 Methods of making an emulsified composition  
The present invention provides a method of making an emulsified composition employing an emulsifier containing a sphingoglycolipid which has a structure represented by the following formula:...
6306613 Modulators of leaderless protein export and methods for identifying and using the same  
Methods of modulating the export of a leaderless protein from a cell by contacting the cell with a compound that alters the binding of the leaderless protein and a transport molecule are provided....
6306376 Use of arbutin monoesters as depigmenting agents  
Arbutin monoesters are employed in a composition for topical application, as a depigmenting and/or bleaching agent for human skin, hair and/or head hair. The invention relates to a method of...
6303580 Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity  
The present invention provides for an isolated A-type substance having a structure identical to an A-type substance obtained from human liver or placenta, which is a cyclical containing...
6299897 Inhibition of selectin binding  
This invention provides compositions for inhibiting the binding between two cells, one expressing P- or L-selectin on the surface and the other expressing the corresponding ligand. A covalently...
6297218 Phospholipid complexes prepared from extracts of Vitis vinifera as anti-atherosclerotic agents  
The phospholipid complex extracts of Vitis vinifera useful for the prevention and the treatment of atherosclerotic pathological conditions and are administered to a patient in need of such treatment.
6294523 Extended type 1 chain glycosphingolipids as tumor-associated antigens  
A variety of compounds are provided which are useful as immunogens and as tumor markers. The present invention discloses methods relating to the detection of cancer. Extended forms of the...
6294521 Phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity  
D-mannoside-6-phosphate compounds having anti-inflammatory activity are disclosed, and use thereof in treating inflammatory diseases, particularly cell-mediated inflammatory diseases.
6290996 Method of inhibiting blood platelet aggregation  
A method of inhibiting blood platelet aggregation in humans which comprises administering an extract blend of the fruit of the Emblica officinalis plant to control said aggregation, suitably in a...
6291433 Derivatives of α-D-Thioxyloside and their use against atheroma  
The present invention concerns, as new industrial products, the α-D-xylose compounds of formula I: ##STR1## wherein X and Y represent, independently of one another, an oxygen atom or a sulphur...
6291435 Treatment of diarrhea caused by enteropathogenic Escherichia coli  
This invention relates to compositions and methods useful to treat diarrhea, especially diarrhea and related conditions initiated or mediated by enteropathogenic E. coli (EPEC), using...
6287798 Esculetin derivatives  
The invention concerns novel 6- or 7-substituted derivatives of esculetin (6,7-dihydroxy-2H-1-benzopyran-2-one), their synthesis, and their application as substrates for the detection of...
6281196 Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin  
6281197 Cardiac glycosides and their aglycone derivatives treat complications of diabetes  
This invention provides methods of inhibiting the export of a leaderless protein from a cell by contacting the cell with a cardiac glycoside or aglycone derivative. Leaderless proteins include...
6280728 Treatment of hepatitis C virus infection using a protease and a flavonoid  
The use of at least one hydrolytic enzyme and at least one flavonoid shows better activity than α-interferon or ribavirin in the treatment of diseases caused by hepatitis C viruses.
6281013 Treatment of Infertility  
In an in vitro fertilization method, a woman is treated with a hypothalamic hormone and/or a pituitary hormone or an agonist or antagonist thereof or an active derivative thereof for a short period...
6274559 Liver protection or treatment agents comprising asiatic acid derivatives as the active component  
Compositions and methods of treating or preventing hepatotoxicity utilizing asiatic acid derivatives of Formula 1 are disclosed. ##STR1##
6274558 Method for treating cardiac malfunction  
A method of treating cardiac malfunction by administering a positive inotropic effect-producing amount of Hypothalamic Inhibitory factor (HIF).
6265383 Treatment of ischemic cardiac malfunction  
The present invention is based on the unexpected discoveries that hypothalamic inhibitory factor (HIF) has a positive inotropic effect in a whole organ preparation, such as an isolated perfused...
6264913 Non-invasive test for assessing bacterial overgrowth of the small intestine  
Provided herein is a novel breath test for assessing bacterial overgrowth. The test involves administration of a labeled sorbitol or sorbitol derivative to a subject and measurement of the label in...
6262038 Germicidal composition  
A germicidal composition suitable for cleaning fruits, vegetables, skin and hair, includes a mixture of fruit acids and a surfactant. The surfactant may be an anionic surfactant (such as sodium...
6261565 Method of preparing and using isoflavones  
The invention provides for a refinement of phytochemicals in order to tailor the refined end product to particular human dietary needs. More particularly, a composition is prepared by extracting...
6258784 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation  
This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure ##STR1## wherein W is S, SO, SO 2 , NR; Y is O, S, NR, or CH 2 ; R is hydrogen or...
6255291 Composition and method for treating cancer and immunological disorders resulting in chronic conditions  
A composition containing alph-alanine, adenosine compound and a glucan. Methods for treating cancer and immunological disorders with said composition.
6245336 Prevention and treatment of acetaminophen toxicity with grape seed proanthocyanidin extract  
A method for preventing and/or reducing the toxicity of acetaminophen is disclosed. An amount of grape seed proanthocyanidin extract effective to inhibit toxicity of acetaminophen is administered...
6242425 Quinolinone glycoside, production process, and anti-allergic agent  
An object is to provide: novel quinolinone glycosides which are useful as medicines; processes for producing the quinolinone glycosides; intermediates for synthesis; and medicines, and particularly...
6242424 Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives  
Moenomycin and its derivatives are suitable for the production of pharmaceuticals for the treatment of gastric ulcers and for the control of Helicobacter pylori.
6242383 Agricultural or horticultural preparation with light stability  
An object of the present invention is to provide an agricultural/horticultural preparation having improved photostability, comprising MK 8383 substance. A composition according to the present...
6239115 Dry flowable polyoxin compositions  
Disclosed are dry flowables containing polyoxin compound, surfactant and water-soluble inorganic material. The dry flowables of the present invention have good friability, dispersibility and...
6235721 Stabilization of vitamin C  
A natural antioxidant blend in the form of an amphorous powder was obtained by extraction from Emblica officinalis fruit. In this process, the finely pulped fruit was treated with a dilute aqueous...
6231859 Saponin adjuvant compositions  
The present invention is in the field of medicinal chemistry. In particular, the invention is related to vaccines comprising novel combinations of saponin adjuvants, to pharmaceutical compositions...
6232294 Neuro-function regulatory agent  
A neuro-function regulatory agent with lesser side effects, comprising glycosyl vitamin P as an effective ingredient. When administered to patients with nerve diseases, the agent exerts a...
6228622 11-hydroxysordarin and a process for producing it using actinomyces SSP  
11-hydroxysordarin, biotransformation product of a fermentation with sordarin and Actinomyces spp., (Merck Culture Collection MA7235) ATCC No. 202103 is an antifungal agent. This compound may be...
6224891 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions  
This invention relates to the treatment of diarrhea and related conditions caused by pathogenic E. coli infection. More specifically, this invention is drawn to the unexpected discovery that by...
6224872 Composition  
A composition which comprises a flavonoid and a processed product of a plant of the genus Pfaffia. The composition effectively maintains and promotes the health, treats and prevents diseases, and...
6221350 Enhancement of microbial colonisation of the gastrointestinal tract  
Probiotic composition comprising one or more probiotic microorganisms, a carrier which will function to transport the one or more probiotic microorganisms to the large bowel or other regions of the...
6218367 Paclitaxel-carbohydrate conjugates: design, synthesis and biological evaluations  
The present invention provides novel, water soluble, carbohydrate derivatives of paclitaxel, methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such...
6217914 Ascorbic acid composition and method for treatment of aging or damaged skin  
An ascorbic acid-based composition and related method for the treatment of aging or photo-damaged skin is disclosed. The composition includes water and ascorbic acid, at least a portion of which...
6203783 Use of alkyl polyglycosides and/or of O-acylated derivatives of glucose for treating hair loss  
6194393 Solution and solid-phase formation of glycosidic linkages  
The invention relates to methods that permit the rapid construction of oligosaccharides and other glycoconjugates. Methods for forming multiple glycosidic linkages in solution in a single step are...
6187754 Sialyl-Lewisa and sialyl-Lewisx epitode analogues  
6187768 Kit for flushing medical devices and method of preparation  
A kit and for flushing a medical device a method of preparing the kit is disclosed. The kit includes a container containing a mixed solution a unit dose of a pharmacologically effective amount of...
6187762 Polyvalent polymers for the treatment of rotavirus infection  
The present invention includes polymerizable monomers comprising a fucoside moiety. In one embodiment, the monomer has a polymerizable functional group, such as an olefinic bond, to which the...